Latest Reports

Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.

FEATURED

2024 IOL Market Report: Global Analysis for 2023 to 2029, March, 2024

The “2024 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success. 

This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs. Additionally, 34 companies are profiled, with discussion of their products, strategic market position, background, and outlook.

2024 Ophthalmic Diagnostic Equipment Market Report: Global Analysis for 2023 to 2029, July, 2024

COMING
SOON
Est. Late July

2024 Ophthalmic Diagnostic Equipment Market Report: Global Analysis for 2023 to 2029, July, 2024

Market Scope’s “2024 Ophthalmic Diagnostic Equipment Market Report” provides in-depth coverage of ophthalmic diagnostic equipment used during ophthalmic exams and procedures, analyzing over 800 devices from 115 manufacturers. This comprehensive report examines the factors shaping the market and identifies trends.  

The report analyzes markets for diagnostic technologies that include corneal topographers, various microscopes, anterior eye scanners, biometers, tonometers, fundus cameras, perimeters, refractors, slit lamps, and many more devices. For each device category, the report discusses pricing, competitor market share, the installed equipment base, and emerging technologies. 

2024 China Ophthalmic Market Report: Regional Analysis for 2023 to 2029, July, 2024

The “2024 China Ophthalmic Market Report” covers all aspects of China’s ophthalmic market, providing a comprehensive overview of the Chinese population and economic conditions, discussing key strategic issues, studying disease prevalence, and analyzing surgical and therapeutic approaches, including both commercialized and pipeline products. The report analyzes unit demand and revenue, and forecasts future performance over the next five years. Competitor share is analyzed by product category and 32 competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

2024 Cataract Surgical Equipment Market Report: Global Analysis for 2023 to 2029, June, 2024

The “2024 Cataract Surgical Equipment Market Report” provides in-depth analysis of the global cataract surgical equipment market, examining the market’s size and growth, as well as identifying important developments that may shape its future. Product coverage includes ultrasonic phaco machines, packs, and accessories; femtosecond laser-assisted cataract surgery systems; and photodisruptor lasers. 

The analysis focuses on the 2024 market and forecasts growth and evolution through 2029. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Additionally, 21 competitors are profiled, with discussion of their products, strategic market position, background, and outlook. 

Ophthalmic Market Perspectives Monthly Newsletter

June, 2024

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.

2024 Glaucoma Pharmaceuticals Market Report: Global Analysis for 2023 to 2029, May, 2024

The “2024 Glaucoma Pharmaceuticals Market Report” analyzes the global and regional markets for glaucoma pharmaceuticals, identifying important trends and key factors for future success. The report provides forecasts through 2029 for branded prostaglandins, generic prostaglandins, beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combo drugs, NO-donating compounds, and Rho-kinase inhibitors. The report also extensively discusses pipeline products, covering over 30 drug candidates that are currently under development. Additionally, 26 glaucoma pharmaceutical companies are profiled, with discussion of their products, strategic market position, background, and outlook.

2024 Annual US Cataract Surgeon Survey Report, May, 2024

Market Scope surveys United States cataract surgeons with an expanded list of questions during the first quarter of each year. Questions probe important issues regarding practice characteristics, product preferences, surgical techniques, and practice marketing and captures market share by manufacturer, product and market segment, and perceptions of companies.

The 2024 survey was conducted during March and April 2024 and received 110 responses from doctors performing cataract procedures, representing over 1 thousand total doctors in single doctor and group practices.  

This survey highlights practice patterns regarding presbyopia-correcting IOLs (PC-IOLs), toric IOLs, extended depth of focus (EDOF) IOLs, correction of astigmatism, femtosecond laser-assisted cataract surgery (FLACS), surgical location, interest in upcoming technology, equipment use, treatment and management of glaucoma and micro-invasive glaucoma surgery (MIGS) devices, and much more. It measures market share by manufacturer, product, and market segment.

Leading ophthalmic firms and organizations sponsor the survey to better understand industry dynamics and gain important insights into surgeons’ experiences and preferences, as well as emerging trends. 

2024 United States Cataract Atlas Featuring the Market Scope Exclusive MedOp Index™ Analysis, April, 2024

The “2024 United States Cataract Atlas” provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.

Ophthalmic Deals Report

Q1, 2024

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

Ophthalmic Market Trends: US Refractive Edition

Q1 - 2024

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Refractive Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more